cGxP.wire https://validator.w3.org/feed/docs/rss2.html LEO Pharma Gains FDA Priority Review for Dersimelagon MaaT Pharma Advances PHOENIX After Negative EMA Opinion Clearmind Briefs FDA on Psychedelic Therapy and Patient Access Adaptive Highlights Updated NCCN MRD Guidance in Multiple Myeloma Telomir Publishes Telomir-Zn AMD Preclinical Findings Hemab Doses First Participant in HMB-003 Phase 1 Capricor to Present Deramiocel HOPE-3 Data at WMS 2026 Lisata Acquires Marea in $225M Cardioendocrine Deal MIRA Advances Ketamir-2 Toward Phase 2a in CIPN Novo Nordisk Gains Positive CHMP Opinion for FREHEMGO Roche Opens Boston Innovation Center for CVRM Research Treace Reports Five-Year ALIGN3D Lapiplasty Outcomes Biogen Reports Positive Pediatric EMPAVELI Data in C3G Avacta Achieves Clinical Proof of Mechanism for AVA6103 LEO Pharma Gains Positive CHMP Opinion for Anzupgo Novo Nordisk Sogroya Gains Positive CHMP Opinion in Europe Johnson & Johnson TECVAYLI Gains Positive CHMP Opinion Roche Ocrevus Gains CHMP Support for Pediatric MS Patients ZBeats Receives FDA Clearance for ZBPro Diagnostic v2.0 Olatec Therapeutics Adds Parkinson’s Disease Experts Astellas PADCEV and Keytruda Gain Positive CHMP Opinion SkinCure Oncology Reports Higher Skin Cancer Incidence Ultragenyx Wins FDA Approval for FAYUVI Gene Therapy Co-Diagnostics Joins WHO Consultation on Global Diagnostics 1ST Biotherapeutics and SK Biopharma License Parkinson’s Drug Avenda Health Brings AI Prostate Cancer Mapping to Arizona Roche Lunsumio Regimen Improves PFS in Follicular Lymphoma Array Behavioral Care Launches Rapid Care for Urgent Needs Insilico Opens AI Toolkit for Global Longevity Research Inductive Bio Launches Beacon-2 for AI Drug Discovery Aethlon Medical Merges With North Immunology for NOR-101 Insilico Medicine Advances AI-Designed BTK Cancer Drugs DarioHealth Expands AI Care to 1.5 Million Lives Nuvation Bio IBTROZI Label Updated With Long-Term Data Novo Nordisk Denecimig Shows Tolerability in Hemophilia A Akeso AK158D1 Gets NMPA Phase I Clearance for Tumors CND Life Sciences Opens New Innovation Lab in Scottsdale Bayer Kerendia Wins FDA Approval for Type 1 Diabetes CKD Enable Biosciences Gains Brazil Approval for T1D Test Teva Launches LongActingImpact.com for Schizophrenia Care Sling Therapeutics Starts Phase 3 Trial of Linsitinib The Braff Group Advises CCR on PhaseWell Partnership Eirion Therapeutics Reports First-in-Human ET-02 Data Lunai Bioworks Advances AI Chemical Risk Screening Onkos Surgical Expands NanoCept Access for Total Femur Care Dualitas Therapeutics and Roche Launch $1B Bispecific Collaboration Fennec Pharmaceuticals Presents Two-Year Pedmark Data in Japan Bristol Myers Squibb Reports Durable Sotyktu Results in PsA Orbis Medicines and Novo Nordisk Form $1.4B Discovery Deal Synergy Spine Solutions Reports Two-Year Synergy Disc Outcomes